366 件 ・ 関連度順
概要と使いどころ
Normalize and screen scattered foreign-trade leads into a conservative, structured lead pool that can flow into customer-intel research. Use when an operator has company names, websites, emails, or contact clues from search results and needs a standardized output with missing-field warnings, review flags, next-step suggestions, and customer-intel-ready JSON.
日本語の概要は準備中です。原文の説明を表示しています。
Run or resume a deliverable active-outreach workflow across lead discovery, screening, customer intel, and outreach email. Use when an operator or system pipeline needs durable run state, visible intermediate artifacts, evidence gates, report-bound human approval, and a final editable email draft that is never auto-sent.
日本語の概要は準備中です。原文の説明を表示しています。
Discover prospect companies from a structured OpenClaw search brief, including public search and user-authorized data sources, then output a conservative candidate list ready for lead screening.
日本語の概要は準備中です。原文の説明を表示しています。
Bilingual JD/CV/Resume tailoring and resume polish skill for job applications. Use when the user provides a job description, JD, role posting, existing CV/resume, LinkedIn profile, portfolio, or career notes and wants to optimize, rewrite, polish, or customize a resume/CV for ATS keywords, recruiter screening, interview-ready evidence, and role fit. 适用于根据招聘 JD、岗位描述、目标公司、现有简历/CV/LinkedIn/profile 进行简历优化、简历润色、岗位匹配、ATS 关键词映射、经历深挖、项目证据提炼和中英文求职简历定制。
日本語の概要は準備中です。原文の説明を表示しています。
Converts a job description into a structured candidate-sourcing workflow. Use when the user provides a role and wants candidate criteria, search terms, source recommendations, and a screening process. Must avoid sourcing on sensitive personal attributes.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates candidate profiles against a job description and hiring criteria. Use when the user provides candidate profiles plus a role definition and wants consistent screening, matched requirements, and an interview recommendation.
日本語の概要は準備中です。原文の説明を表示しています。
Choose the design and the numbers a research run can honestly claim — write the structured METHOD RECORD (databases, date of access, search string, criteria, screening counts) that r0 validates, pick the claim strength a design can actually carry, record a statistic as data rather than prose, route to the reporting guideline the design owes, and decide what to preregister. Use when a run's question, design, search or statistics have to be settled before the writing, or when a claim needs a strength or a number attached to it.
日本語の概要は準備中です。原文の説明を表示しています。
Knowledge base from the NIST/SEMATECH e-Handbook of Statistical Methods (NIST HB 151) — the practical statistics reference for engineering, metrology, and quality. Use for: exploratory data analysis and the four univariate assumptions (4-plot); measurement process characterization including bias/precision, calibration designs, gauge R&R, and ISO/GUM uncertainty budgets; production process characterization (stability vs. capability); process modeling and regression (LS/WLS/NLS/LOESS); design of experiments (screening, fractional/factorial, response-surface, Taguchi); statistical process control (Shewhart/CUSUM/EWMA charts, capability indices, acceptance sampling); product/process comparisons (hypothesis tests and confidence intervals for 1/2/3+ groups, ANOVA, multiple comparisons); and reliability (lifetime & repair-rate models, accelerated testing, reliability growth). Scope limits: this is applied frequentist statistics for measurement and quality — it does NOT reproduce the per-distribution formula galleries, worked case studies, datasets, plot images, or Dataplot/R code of the original web Handbook (those are described, not copied); it is thin on modern machine learning, Bayesian methods beyond conjugate reliability priors, time-series/forecasting, and Bayesian experimental design.
日本語の概要は準備中です。原文の説明を表示しています。
Knowledge base from the DoD Manufacturing Readiness Level (MRL) Deskbook (Version 2022, OSD ManTech / Joint Service–Industry MRL Working Group). Use for assessing and managing manufacturing maturity and producibility risk in defense acquisition: the 10-level MRL scale and its non-linear, target-not-grade nature; the five demonstration environments (laboratory → production-relevant → production-representative → pilot line → production line); the nine manufacturing-risk threads and sub-threads; how MRL targets map onto Adaptive Acquisition Framework milestones (MRL 4/6/7/8/9); conducting an MRL Assessment; building a Manufacturing Maturation Plan; putting MRL maturity into contract language (Section L/M, SOW, AS6500A, DIDs); tailoring criteria for S&T, single-system, ship, sustainment, and industry contexts; and screening operational-technology cybersecurity. Manufacturing-readiness focused — it measures producibility risk and frames mitigation; it is NOT a technology-readiness (TRL) guide, a full systems-engineering process model, a cost-estimating or schedule guide, or a deep cybersecurity audit method (see sibling packs for those).
日本語の概要は準備中です。原文の説明を表示しています。
Compares one clause (liability, termination, confidentiality or any other) across several contracts, templates or successive versions and returns a DRAFT comparison table: verbatim clause text per document, the clause split into elements with every difference from the baseline highlighted and categorised, and neutral questions for counsel. Never says which wording is better or enforceable. Use when the user asks to "compare the liability caps across these five supplier contracts", "line up the termination clause in these three drafts", "show how the confidentiality clause changed between versions", "contrast this clause with our template" or "benchmark the indemnity wording across our customer agreements". Do not use for a whole-contract review, use contract-review-pack instead; for screening one NDA against standard positions, use nda-triage. Drafts for human review; never approves, authorises or signs off.
日本語の概要は準備中です。原文の説明を表示しています。
Reviews one employee software request (tool, purpose, users, data handled, cost, urgency) against the approved-tools list and the policies the user provides and returns a draft review for the reviewer: match state on the list with the row quoted, approved tools the list itself describes as covering the same need, policy clauses that bear on the request with quoted text, questions for the requester and the reviewer, and one suggested decision with its basis. Never approves, procures, installs or adds a tool to the list. Use when the user asks to "review this software request", "is this tool on the approved list", "check this request against our software policy", "do we already have something approved that does this" or "prepare the decision note for this tool request". Do not use for a full vendor security assessment, use vendor-risk-screening-brief instead; for sorting mixed requests, use request-intake-triage. Drafts for human review; never approves, authorises or signs off.
日本語の概要は準備中です。原文の説明を表示しています。
財務指標の条件（ROE・PBR・配当利回り・自己資本比率等）で日本株を絞り込む時に使う。「ROE15%以上でPBR1倍以下の企業を探して」「配当利回りが高い企業ランキング」のような、条件検索・ランキング指示で発火する。
- Entry point for open-source intelligence, investigation and verification work. Use when asked to investigate, research, verify, vet, check out, look up, background-check, trace, attribute or find someone or something; when a request involves due diligence, KYC or KYB, counterparty or vendor risk, sanctions and PEP screening, AML, fraud, business email compromise
日本語の概要は準備中です。原文の説明を表示しています。
Design and interpret TypeSafe Jev decision requests in NV oOS — typed choice/score/noul questions, batching, confidence thresholds, composite scoring, and guardrails. Use when classifying, routing, scoring, or safety-screening content with the typesafe_decide or typesafe_guardrail tools.
日本語の概要は準備中です。原文の説明を表示しています。
Use when the user asks to "find influencers", "build an influencer list", or "discover creators in [niche]"; produces a multi-platform candidate pool, per-influencer profiles, authenticity red-flag screening, and a tiered shortlist with preliminary triage signals. Not for STAR scoring or ranking a known shortlist — use fit-scorer. 达人挖掘/找达人/创作者名单
日本語の概要は準備中です。原文の説明を表示しています。
Marketing analytics and data-driven optimization for B2B SaaS campaigns. Use this skill when analyzing marketing performance, optimizing conversion rates, running A/B tests, conducting customer research, creating marketing dashboards, building attribution models, analyzing funnel metrics, or storytelling with data. Also triggers on: marketing ops, performance analytics, CRO, A/B testing, data storytelling, customer insights, tracking plan, event taxonomy, UTM taxonomy, GA4 audit, consent mode, instrumentation contract, sample size calculation, minimum detectable effect, test duration, not enough traffic to A/B test, statistical significance, Bayesian vs frequentist, sample ratio mismatch, experiment feasibility, martech stack, marketing tech stack audit, tool consolidation, build vs buy, vendor evaluation, shadow IT tools, ESP/CRM/platform migration, switching cost, cutover plan, suppression list migration, data portability, customer interviews, survey design, sampling frame, non-response bias, how many people should I interview, thematic saturation, voice of customer, jobs-to-be-done, buyer persona research, is this finding real, data enrichment, which enrichment provider should we buy, waterfall enrichment, contact data quality, match rate, our list data is bad, email verification, catch-all domain, accept-all, bounce rate from bad data, B2B data decay, how often should we re-verify contacts, ZoomInfo vs Apollo vs Clearbit evaluation, cost per usable record, where did this list come from, GDPR Article 14 notice, purchased list compliance, suppression screening, TAM list building, demand planning, marketing plan, how many leads do we need, what pipeline target should marketing carry, funnel model, top-down vs bottom-up plan, plan of record, annual marketing planning, quarterly planning, pipeline coverage we have to create, sales cycle lag, our leads cannot close this quarter, carry-in pipeline, scenario planning, conservative moderate aggressive forecast, stretch target, reforecast, re-forecast triggers, assumption register, capacity ceiling, addressable audience ceiling, marginal cost per lead, blended CPL is wrong, we missed plan and nobody knows why.
日本語の概要は準備中です。原文の説明を表示しています。
How to use the Adaptyv Bio Foundry API and Python SDK for protein experiment design, submission, and results retrieval. Use this skill whenever the user mentions Adaptyv, Foundry API, protein binding assays, protein screening experiments, BLI/SPR assays, thermostability assays, or wants to submit protein sequences for experimental characterization. Also trigger when code imports `adaptyv`, `adaptyv_sdk`, or `FoundryClient`, or references `foundry-api-public.adaptyvbio.com`.
日本語の概要は準備中です。原文の説明を表示しています。
Molecular docking with AutoDock Vina (Python API). Receptor/ligand prep (Meeko + RDKit), grid box, docking, pose and binding energy analysis, and batch virtual screening.
日本語の概要は準備中です。原文の説明を表示しています。
Dose-response / concentration-response curve fitting — IC50, EC50, Hill slope, Emax/Emin efficacy, and relative potency from paired concentration vs response data (enzyme/cell assays, drug screening, agonist/antagonist pharmacology). Fits the 4-parameter logistic (Hill sigmoidal) model. Use when you have concentrations + responses and need a potency value, to compare two compounds' potency, or to judge curve quality. NOT for image-derived dose-response (use tooluniverse-image-analysis) and NOT for survival/regression (use tooluniverse-statistical-modeling).
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling for drug candidates. Integrates ADMET-AI predictions, SwissADME drug-likeness, PubChemTox experimental toxicity, ChEMBL clinical data, Lipinski rule-of-five, and CYP interaction data. Use for drug-likeness assessment, BBB penetration, bioavailability, hepatotoxicity prediction, ADME/PK profiling, or screening compound libraries before lab testing.
日本語の概要は準備中です。原文の説明を表示しています。
Performs retrosynthetic planning using AiZynthFinder (MCTS, template-based), Chemformer (template-free transformer), ASKCOS, and emerging RetroSynFormer with explicit handling of route scoring, building-block availability (eMolecules, Enamine, Mcule), forward prediction validation (Molecular Transformer), and disconnection-aware multi-objective search (MO-MCTS). Use when assessing synthetic feasibility of generated or selected molecules, planning multi-step syntheses, building synthesis-aware design pipelines, or screening libraries for retro-route feasibility.
日本語の概要は準備中です。原文の説明を表示しています。
Searches molecular libraries for substructure matches using SMARTS patterns with explicit handling of recursive SMARTS, ring membership, aromaticity dialect, vector binding, atom map indices, and reactive/PAINS/REOS/Brenk/Aldridge filter catalogs. Use when filtering compounds by pharmacophore features, functional groups, scaffold matches, or screening for assay-interference / structural alerts.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates molecular fingerprints (ECFP/Morgan, FCFP, MACCS, RDKit, AtomPair, TopologicalTorsion, Avalon, MAP4, MHFP6) and physicochemical descriptors (Lipinski, QED, TPSA, Crippen LogP, 3D shape) with explicit choice tables, bit vs count semantics, and partial-charge model selection. Use when featurizing molecules for similarity, QSAR, virtual screening, or ML, or selecting the correct fingerprint for a chemotype-aware task.
日本語の概要は準備中です。原文の説明を表示しています。
Builds and applies 3D pharmacophore models using RDKit Pharm3D, the apo2ph4 receptor-based workflow (Heider et al 2022/2023 J Chem Inf Model 63:147-158), Pharmer / Pharmit (search), and PharmacoForge (diffusion-based generation, Flynn et al 2025 Front Bioinform), covering ligand-based pharmacophore (from active set alignment) and receptor-based pharmacophore (from binding pocket geometry). Explicit handling of feature types, geometric tolerances, partial matching, and pharmacophore-based virtual screening. Use when identifying scaffold-hopping candidates, building shape-and-feature search queries, or transferring SAR across chemotypes.
日本語の概要は準備中です。原文の説明を表示しています。